Depression and anxiety in multisomatoform disorder : prevalence and clinical predictors in primary care

SUNScholar Research Repository

Show simple item record

dc.contributor.author Muller, Jacqueline E.
dc.contributor.author Wentzel, Ignatius
dc.contributor.author Nel, Daniel G.
dc.contributor.author Stein, Dan J.
dc.date.accessioned 2011-03-18T14:56:54Z
dc.date.available 2011-03-18T14:56:54Z
dc.date.issued 2008
dc.identifier.citation Muller, J.E., Wentzel, I., Nel, D.G. & Stein, D.J. 2008. Depression and anxiety in multisomatoform disorder : prevalence and clinical predictors in primary care. South African Medical Journal, 98(6) 473-476, http://www.samj.org.za/index.php/samj
dc.identifier.issn 02569574 (print)
dc.identifier.issn 20785135 (EISSN)
dc.identifier.uri http://hdl.handle.net/10019.1/7050
dc.description The original publication is available at http://www.samj.org.za
dc.description.abstract Objective. Multisomatoform disorder (MSD) is characterised by ≥3 medically inexplicable, troublesome physical symptoms, together with a ≥2-year history of somatisation. The aim of this study was to evaluate the prevalence of depressive and anxiety disorders in a South African sample MSD, and to compare demographic and clinical outcomes in those patients with and without co-morbidity. Methods. Fifty-one adult outpatients with MSD were recruited from primary care clinics in the Cape Town metropole. Participants were assessed for the presence of co-morbid depressive and anxiety disorders using the Mini Neuropsychiatric Interview-Plus (MINI-Plus). Outcomes included somatic symptom severity, disability, reported sick days and health care visits, pain experience, patient satisfaction with health services, and clinician-experienced difficulty. Results. A current co-morbid depressive disorder was present in 29.4% (N=15) of patients, and a current co-morbid anxiety disorder in 52.9% (N=27). MSD patients with a co-morbid depressive disorder (current or lifetime) had significantly higher physical symptom counts, greater functional impairment, higher unemployment rates, more clinician-reported difficulties, and more dissatisfaction with health care services than those without the disorder. A larger number of co-morbid disorders was associated with greater overall disability. Conclusion. High rates of co-morbid depressive and anxiety disorders were present in a South African sample of primary care patients with MSD. Not all patients had co-morbidity, which is consistent with the view that MSD should be viewed as an independent disorder. However, co-morbid depressive disorders were associated with increased symptom severity and functional impairment, consistent with previous reports from developing countries, emphasising the importance of comorbidity in MSD. en_ZA
dc.language.iso en_US
dc.publisher Health and Medical Publishing Group (HMPG)
dc.subject Multisomatoform disorder en_ZA
dc.subject Depression en_ZA
dc.subject Anxiety en_ZA
dc.title Depression and anxiety in multisomatoform disorder : prevalence and clinical predictors in primary care en_ZA
dc.type Article
dc.description.version Publishers' version
dc.rights.holder Health and Medical Publishing Group (HMPG)


Files in this item

This item appears in the following Collection(s)

Show simple item record